New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Based on 51 included studies, the researchers found that the pooled incidences of CAD, acute coronary syndromes, and myocardial infarction (MI) were 2.28, 2.02, and 1.80 percent, respectively. There ...